newsfilter
← Latest News
GlobeNewswire·

As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives

NEW YORK, NY, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ:APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, announces